BridgeBio Pharma, Inc.

BBIO · NASDAQ
Analyze with AI
$76.30+$2.16 (+2.91%)
At close:Dec 19, 2025, 9:00 PM UTC
$76.30+$0.00 (+0%)
After hours:Dec 19, 2025, 10:32 PM UTC
P/E TTM-18.24
P/B TTM-7.56
P/S TTM41.09
Dividend Yield0%
EPS-$4.22
Beta1.257
Valuation
PEG Ratio7.46
FCF Yield-4.05%
EV / EBITDA-20.53
More On Valuation »
Quality
ROIC-77.66%
Gross Margin95.78%
Cash Conv. Ratio0.73
More On Quality »
Growth
Revenue 3Y CAGR41.91%
FCF Growth1.39%
More On Growth »
Safety
Net Debt / EBITDA0.94
Interest Coverage-5.03
More On Safety »
Efficiency
Inventory Turnover0.61
Cash Conv. Cycle262.53
More On Efficiency »

BridgeBio Pharma, Inc. (BBIO) stock FAQs

Quick answers sourced from live Financial Modeling Prep fundamentals and AlphaPilot portfolio guidance.

What is BridgeBio Pharma, Inc. (BBIO) stock price today?

As of Dec 19, 2025, 9:00 PM UTC, BridgeBio Pharma, Inc. (BBIO) stock is trading at $76.30. The stock price is quoted in USD and refreshes in real-time throughout the trading day. AlphaPilot provides live market data powered by Financial Modeling Prep's institutional-grade API, ensuring you get accurate and up-to-date BBIO stock quotes for informed trading decisions.

What is BridgeBio Pharma, Inc.'s market capitalization?

BridgeBio Pharma, Inc. (BBIO) has a market capitalization of approximately $14.5B. Market cap is calculated by multiplying the current share price by the total number of outstanding shares. This valuation metric helps investors compare BridgeBio Pharma, Inc.'s size relative to other companies in the USD market. The market cap figure updates automatically as the BBIO stock price changes.

What is the 52-week range for BridgeBio Pharma, Inc. stock?

BridgeBio Pharma, Inc. (BBIO) stock has traded in a 52-week range of $26.02 — $77.20. The 52-week range shows the highest and lowest prices at which BBIO traded over the past year, helping investors assess price volatility and identify potential support and resistance levels. Comparing the current BridgeBio Pharma, Inc. stock price to this range provides context for recent price action.

How much trading volume does BridgeBio Pharma, Inc. stock have?

BridgeBio Pharma, Inc. (BBIO) stock recently traded approximately 4.7M shares. Trading volume indicates market liquidity and investor interest in BBIO. Higher volume typically suggests active participation and can signal important price movements or news catalysts affecting BridgeBio Pharma, Inc. stock.

Does BridgeBio Pharma, Inc. pay dividends to shareholders?

Yes, BridgeBio Pharma, Inc. (BBIO) currently offers a dividend yield of approximately 0%. Dividend yield is calculated by dividing the company's annual dividend payments by the current stock price, expressed as a percentage. This metric helps income-focused investors evaluate BridgeBio Pharma, Inc. stock's potential for generating passive income. Dividend data reflects the trailing twelve months (TTM) of distributions.

What is BridgeBio Pharma, Inc.'s intraday price range?

Today, BridgeBio Pharma, Inc. (BBIO) stock has traded in a range of $74.20 — $77.20. The intraday range represents the lowest and highest prices reached during the current trading session. Monitoring BBIO's intraday volatility helps traders identify entry and exit points, while comparing it to the 52-week range provides perspective on short-term versus long-term price movements.

Where does AlphaPilot get BridgeBio Pharma, Inc. stock data?

AlphaPilot sources real-time BBIO stock quotes, fundamental financial data, and historical price charts for BridgeBio Pharma, Inc. from Financial Modeling Prep's institutional-grade API. This enterprise data feed provides live market prices during trading hours, along with comprehensive fundamentals that update after each earnings release, SEC filing, or corporate action. The BridgeBio Pharma, Inc. stock summary page combines intraday price movements with key metrics like P/E ratio, market cap, dividend yield, and balance sheet data to give investors a complete view of BBIO stock performance.